Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05821101 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Dec 31, 2025 to Jan 31, 2025
    • Site details revised
    v4
  2. Primary completion date: Dec 2023 to Dec 31, 2025
    • Study completion date: Dec 2024 to Jun 2026
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2023 to Apr 6, 2023
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Purpose is to study the clinical outcomes of Clareon Vivity and Clareon Vivity Toric intraocular lens (IOL) implants in patients who are planning to have cataract surgery in both eyes with a mini-monovision approach.
Trial Details
NCT Number NCT05821101
Lead Sponsor Debbie S. Kuo, MD
Collaborators: Alcon Research
Conditions
(from sponsor)		 Aphakia, Postcataract
Related terms Aphakia, Postcataract
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov